Womble Bond Dickinson (US) LLP
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
The present disclosure relates to pharmaceutical compositions of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and corresponding methods of treating psoriatic arthritis.
AbbVie Inc.
A A A A A C A A C A A A
A61K A61K A61P A61K A61K C07B A61K A61K C07D A61K A61K A61K
inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional
Aileen L. Ahmed A. Jaclyn Kay Ben Mohamed-Eslam F.
Pangan Othman Anderson Klünder Mohamed